RECAPTURE RATES WITH IXEKIZUMAB AFTER WITHDRAWAL OF THERAPY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS AT WEEK 104 FROM A RANDOMIZED PLACEBO-CONTROLLED WITHDRAWAL STUDY

被引：0
|
作者：
Landewe, Robert B. M. [1 ]
Poddubnyy, Denis [2 ]
Rahman, Proton [3 ]
Bolce, Rebecca [4 ]
Liu-Leage, Soyi [4 ]
Lisse, Jeffrey [4 ]
Leung, Ann [5 ]
Park, So Young [4 ]
Gensler, Lianne S. [6 ]
Bird, Paul [7 ]
机构：
[1] Amsterdam Rheumatol & Immunol Ctr, Dept Clin Immunol & Rheumatol, Amsterdam, Netherlands
[2] Charite, Hindenburgdamm, Germany
[3] Mem Univ Newfoundland, St John, NF, Canada
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Syneos Hlth, Morrisville, NY USA
[6] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[7] Conjoint Prof UNSW, Sydney, NSW, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ARA-P70
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [1] Recapture Rates with Ixekizumab After Withdrawal of Therapy in Patients with Axial Spondyloarthritis: Results at Week 104 from a Randomized Placebo-controlled Withdrawal Study
    Landewe, Robert
    Poddubnyy, Denis
    Rahman, Proton
    Bolce, Rebecca
    Liu-Leage, Soyi
    Lisse, Jeffrey
    Park, So Young
    Gensler, Lianne
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 853 - 854
  • [2] RECAPTURE RATES WITH IXEKIZUMAB AFTER WITHDRAWAL OF THERAPY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS AT WEEK 104 FROM A RANDOMIZED PLACEBO-CONTROLLED WITHDRAWAL STUDY
    Landewe, R. B. M.
    Poddubnyy, D.
    Rahman, P.
    Bolce, R.
    Leage, S. Liu
    Lisse, J.
    Leung, A.
    Park, S. Y.
    Gensler, L. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 10 - 11
  • [3] Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study
    Landewe, Robert B. M.
    Poddubnyy, Denis
    Rahman, Proton
    Van den Bosch, Filip E.
    Bolce, Rebecca
    Liu Leage, Soyi
    Lisse, Jeffrey R.
    Park, So Young
    Gensler, Lianne
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (02) : 212 - 216
  • [4] Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)
    Landewe, Robert B. M.
    Gensler, Lianne S.
    Poddubnyy, Denis
    Rahman, Proton
    Hojnik, Maja
    Li, Xiaoqi
    Liu Leage, Soyi
    Adams, David
    Carlier, Hilde
    Van den Bosch, Filip
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08) : 1022 - 1030
  • [5] Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16-and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
    Xue, Yu
    Hu, Jiankang
    Liu, Dongzhou
    Li, Jingyang
    Wu, Huaxiang
    Tan, Chunyu
    Dai, Lie
    Sun, Lingyun
    Li, Zhijun
    Xiao, Zhengyu
    Huang, Cibo
    Yan, Yan
    Ji, Fei
    Chen, Rong
    Zou, Hejian
    BIODRUGS, 2024, 38 (01) : 145 - 156
  • [6] Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
    Yu Xue
    Jiankang Hu
    Dongzhou Liu
    Jingyang Li
    Huaxiang Wu
    Chunyu Tan
    Lie Dai
    Lingyun Sun
    Zhijun Li
    Zhengyu Xiao
    Cibo Huang
    Yan Yan
    Fei Ji
    Rong Chen
    Hejian Zou
    BioDrugs, 2024, 38 : 145 - 156
  • [7] Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study
    Correll, Christoph U.
    Kohecyi, Eva
    Zhao, Cathy
    Baker, Ross A.
    McQuade, Robert
    Salzman, Phyllis
    Sanchez, Raymond
    Nyilas, Margaretta
    Carson, William
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (09): : 784 - 792
  • [8] RANDOMIZED WITHDRAWAL FROM NIFEDIPINE - PLACEBO-CONTROLLED STUDY IN PATIENTS WITH CORONARY-ARTERY SPASM
    SCHICK, EC
    LIANG, CS
    HEUPLER, FA
    KAHL, FR
    KENT, KM
    KERIN, NZ
    NOBLE, RJ
    RUBENFIRE, M
    TABATZNIK, B
    TERRY, RW
    AMERICAN HEART JOURNAL, 1982, 104 (03) : 690 - 697
  • [9] Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo-Controlled, Phase 3 Study
    Deodhar, Atul
    Supronik, Jerzy
    Kivitz, Alan
    Valenzuela, Guillermo
    Kapur, Karen
    Rohrer, Susanne
    Dokoupilova, Eva
    Richards, Hanno B.
    Pavelka, Karel
    ARTHRITIS & RHEUMATOLOGY, 2024,
  • [10] Benefits of propentofylline therapy persist after drug withdrawal: Results of a double-blind, placebo-controlled study
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1998, 46 (09) : S68 - S68
12345